amfAR, The Foundation for AIDS Research
amfAR plays a vital role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS, and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders.
Researchers are pioneering gene therapy approaches to target and eliminate the HIV reservoir.
New Krim Fellows will harness powerful technologies in support of HIV vaccine and latency studies.
Grants awarded through amfAR Fund to Fight COVID-19 will investigate “long-haulers” and effect of coronavirus on HIV reservoir.
A potentially groundbreaking clinical trial will test a combination HIV cure strategy.
While we remain firmly committed to curing HIV, amfAR is applying its experience and expertise to the fight against COVID-19.
amfAR grantee Scott Kitchen is testing “second generation” CAR T cells with enhancements that show exciting potential.
Our dedicated page contains video interviews, news and data on the intersection between HIV and COVID.